Search CROs

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase IV / Post-Marketing

Real-world data platform and health data network serving life sciences, payers, and providers with privacy-first connectivity, evidence generation, and data analytics across 80,000+ hospitals and clinics.

• Biostatistics & Statistical Programming
• Clinical Operations
• Data Management & eClinical

Optum is a leading healthcare company that provides integrated medical, pharmacy, and financial services across the United States. Founded in April 2011 as a UnitedHealth Group company, Optum serves more than 120 million people through a network of doctors and care teams. The…

• Biostatistics & Statistical Programming
• Clinical Operations
• Data Management & eClinical

Strategy, research, clinical development, and transformation consulting for biopharma. Combines Putnam, Research Partnership, STEM, and Vynamic to deliver end-to-end expertise from pipeline to launch.

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Central Laboratory Services

Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

YPrime delivers configurable eCOA, IRT, and eConsent clinical trial technology platforms with consulting services, supporting ~1,000 studies globally across 19+ therapeutic areas.

• Clinical Operations
• Clinical Trial Services
• Medical Writing

Pharmacovigilance and safety services provider offering end-to-end operations, technology-driven solutions, and specialized expertise in vaccines, CGT/ATMP, pediatric medicines, and geriatric populations.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Global CRO and FSP provider with 25+ years of experience delivering integrated clinical research solutions across North America, Europe, LATAM, and APAC.

• Clinical Operations
• Phase I Clinical Trials
• Phase II Clinical Trials

Global, full-service CRO specializing in oncology and rare disease clinical solutions from proof-of-concept through commercialization.

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Central Laboratory Services

ICON is a CRO with 8,000 biotech-dedicated professionals offering end-to-end clinical development, consulting, and therapeutic expertise across all development phases.

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Clinical Imaging Core Lab

Specialized CRO supporting clinical development in neuroscience and metabolic disease across all phases, with direct access to 20 wholly-owned US research sites and 400+ beds.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience.

• Bioanalysis
• Biomarker Assays
• Clinical Imaging Core Lab

Bioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise.

• Analytical Method Development & Validation
• Bioanalysis
• Bioinformatics & Data Science

Full-service CRO and CDMO with specialized competency centers in drug discovery, formulation development, GMP manufacturing, and bioanalytical services across Germany and France.

• Analytical Method Development & Validation
• Bioanalysis
• Biomarker Assays

Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Full-service CRO with over 30 years of experience offering clinical trials, biostatistics, medical writing, and health economics services across all phases of development.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Integrated clinical research site organization operating 60+ sites across the U.S. and Europe, supporting trials that contributed to 61 FDA-approved products since 1986.

• Bioanalysis
• Clinical Operations
• Phase I Clinical Trials

Full-service CRO founded in 1999 providing therapeutic expertise across clinical trial and consulting services to pharmaceutical and biotechnology companies.